Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-Blind, Randomized, Split-Face Study to Evaluate the Safety and Efficacy of Revanesse® Ultra Versus Restylane® for the Correction of Nasolabial Folds

NCT02987205 is registered in ClinicalTrials.gov with Prollenium Medical Technologies Inc. as lead sponsor.

NCT NCT02987205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02987205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-Blind, Randomized, Split-Face Study to Evaluate the Safety and Efficacy of Revanesse® Ultra Versus Restylane® for the Correction of Nasolabial Folds
Lead sponsor
Prollenium Medical Technologies Inc.
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2015
Completion date
September 30, 2016
Enrollment
163 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

nasolabial fold correction